CompletedNot Applicable

TB-CAPT EXULTANT - HIV

Mozambique, Tanzania1,172 participantsStarted 2022-09-05

Plain-language summary

The overall aim of this study is to assess the potential of an expanded TB testing strategy to increase the number of HIV-positive patients with microbiologically diagnosed TB who are started on treatment in adult wards of sub-Saharan Africa.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults (18 years old and above)
✓. Confirmed HIV infection by serology (including both antiretroviral (ART)- naïve and experienced)
✓. Admitted to the hospital (adult medical wards) at the time of enrolment.

Exclusion criteria

✕. Unable to provide informed consent (if no authorized relatives are in the position to provide the consent)
✕. Living outside the catchment area of the participating hospital(s)
✕. with plans to migrate outside the catchment area within 2 months after recruitment.
✕. Currently receiving anti-TB therapy or having received anti TB therapy in the last 6 months prior to enrolment
✕. Receiving preventive TB treatment in the preceding 6 months
✕. Patients admitted for traumatic reasons, acute abdomen, delivery (maternal conditions), or for planned/scheduled surgery.
✕. Referred from other hospital.

What they're measuring

proportion of participants diagnosed with microbiologically confirmed TB and started on TB treatment within 72 hours of enrolment

Timeframe: 72 hours after enrolment

Trial details

NCT IDNCT04568967

SponsorFoundation for Innovative New Diagnostics, Switzerland

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Tuberculosis trials